About Thomas Struengmann
Thomas Strungmann, a billionaire hailing from Germany, is the co-founder of Hexal AG, a company that specialised in manufacturing generic drugs. Together with his identical twin brother Andreas, the company managed to earn a staggering $1.6 billion in 2004. The business was sold by the brothers the following year for a staggering $6.7 billion.
It is essential to note that Thomas Strungmann’s accomplishments transcend the pharmaceutical sector. In addition to his position at Santo Venture Capital, he has made significant investments in the technology sector. Additionally, he made investments in the German long-distance bus company Flixbus and the software company TeamViewer, which went public in 2019. Thomas Strungmann is a German billionaire who co-founded Hexal AG and invested heavily in BioNTech to amass a sizable fortune. He is a co-founder of Santo Venture Capital and holds a doctorate in economics.
Thomas Struengmann Education
Thomas Struengmann was brought into the world in 1950 in Tegernsee, Germany, as an indistinguishable twin sibling to Andreas. Thomas received his doctorate in economics, while Andreas received his medical degree. They joined their father’s Durachemie, which he had started ten years earlier, in 1979.
Thomas Struengmann Career
While Thomas and his brother Andreas are well-known for co-founding generic drug manufacturer Hexal AG in 1986, he is also well-known for his significant investments in BioNTech SE. The Struengmann siblings were early supporters of BioNTech, and their stake in the organisation has assisted them with storing up a huge fortune.
Thomas Struengmann has accomplished a lot in the pharmaceutical industry, particularly in drug development and investment. He is now one of the richest people in the world because of his success with BioNTech in particular. It would be fascinating to dive more deeply into his childhood and early life, yet tragically, there are relatively few subtleties accessible on this theme.
Thomas Struengmann Facts
Through their family office, they invest in a variety of industries, with a focus on pharmaceuticals and biotech. Additionally, they are well known for their significant investments in the creation of the COVID-19 vaccine.
Thomas Struengmann Net Worth
According to the billionaire list, his net worth as of 2023 is around $10.7 billion.
Personal Information
| Full Name | Thomas Struengmann |
| Father’s Name | Ernst Struengmann |
| Mother’s Name | Not Mention |
| Siblings | Andreas Struengmann |
| Date Of Birth | In 1950 |
| Age | 73 Years |
| Birth Place | German |
| Height | Not Mention |
| Education | Graduate |
| Net Worth | $10.2 Billion |
| Profession | Entrepreneur |
| Relationship Status | Married |
Also Read:
Kumar Birla Net Worth, Age, Family & Biography